Eledon Pharmaceuticals, Inc.
ELDN • NASDAQ • Stock Fundamentals
Eledon Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David-Alexandre C. Gros, with a market cap of $300.3M.
Market Cap$300.3M
Employees20.0
CEODavid-Alexandre C. Gros
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 13, 2026 · 15 days agoQ1 2026
View reportNext EarningsAug 13, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
Eledon Pharmaceuticals, Inc. FAQ
Common questions about Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals, Inc. (ELDN) has a market capitalization of $300.3M and trades on NASDAQ.
Eledon Pharmaceuticals, Inc. has approximately 20 employees.